The data of the RESA 2023 study of health outcome indicators in private healthcare They showed up this morning. Juan Abarca, president of the IDIS foundation, has detailed that, after a few years marked by the Covid-19 pandemic, the report has been resumed in its ninth edition. “It’s a transparency exercise of private sector hospitals that has not been able to be done since 2019, because the data was skewed by the pandemic. The results allow us to improve processes and generate competitiveness. Because, if something is not measured, it does not improve” he highlighted.
The RESA study has been detailed by Martha Villanuevageneral director of the IDIS Foundation and Nicolas Guerra, general director of IMQ clinics. The work has counted, in this year’s edition, with more than 500 participants and more than 100 indicators -30 of them new- that have evaluated 130 private hospitals, 120 outpatient centers and 311 assisted reproduction centers. Conducted by the consulting firm IQVIA, in total data has been collected from more than 700,000 hospital discharges analyzed, some five million visits to the emergency room collected, almost five million visits to outpatient clinics and some 100,000 fertility cycles have been analyzed. All the data can be consulted on the IDIS foundation website.
“The Private healthcare has been able to adapt and respond to the needswith a very representative sample, with an exponential growth of centers and indicators since we began to prepare these reports in 2012. We promote continuous improvement, transparency and competitiveness between centers, because we must continue improving,” Villanueva summarized.
The first point of contact between a patient and their healthcare is the accessibility that the patient has with the healthcare system: private healthcare continues to show a downward trend with respect to the previous RESA study in average waiting times for the appointment for radiodiagnostic tests (mammography, CT and MRI) and the delivery of these same reports. “These declines are due to innovation,” said Villanueva.
A similar downward trend is observed with respect to the average waiting times for appointments for laboratory tests (biochemistry and hematology or microbiology, genetics and immunology), being less than one day in any case. Also The same thing happens with the average waiting times for the delivery of laboratory reports.which show that their results are received as soon as the laboratory results are known: on the same day in the case of biochemistry, and in less than two days in microbiology, immunology and genetics.